A2DMQY Cronos Group Inc

Cronos Group to Delay 2019 Fourth Quarter and Full-Year Earnings Release and Conference Call

Cronos Group to Delay 2019 Fourth Quarter and Full-Year Earnings Release and Conference Call

TORONTO, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that it will delay its 2019 fourth quarter and full-year earnings release and conference call, previously scheduled for Thursday, February 27, 2020. The Company has had a delay in the completion of its financial statements and will make a further announcement in a subsequent press release to schedule the date and time of the earnings conference call.

About Cronos Group

Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos Group is building an iconic brand portfolio. Cronos Group’s portfolio includes ™, a global health and wellness platform, two adult-use brands, ™ and ™, and two hemp-derived CBD brands, ™ and ™. For more information about Cronos Group and its brands, please visit:

Cronos Group Contact

Anna Shlimak

Tel: (416) 504-0004

EN
24/02/2020

Underlying

A2DMQYCronos Group Inc

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cronos Group Inc

 PRESS RELEASE
Free
A2DMQY Cronos Group In...

Cronos Group Inc. to Hold 2025 Fourth Quarter and Full-Year Earnings C...

Cronos Group Inc. to Hold 2025 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2026 TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 fourth quarter and full-year earnings conference call on Thursday, February 26, 2026 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at . To...

February 12, 2026 1 EN
 PRESS RELEASE
Free
A2DMQY Cronos Group In...

Cronos Group משיקה את מותג הפרימיום Lord Jones® בישראל ומקדמת אסטרטגי...

Cronos Group משיקה את מותג הפרימיום Lord Jones® בישראל ומקדמת אסטרטגיית מוצרים גלובלית חוצת גבולות טורונטו, Feb. 02, 2026 (GLOBE NEWSWIRE) --  חברת Cronos Group Inc. (NASDAQ: CRON; TSX: CRON) (“קרונוס” או “החברה”), מהחברות הגלובליות המובילות בעולם הקנאבינואידים, הודיעה היום על השקת מותג הקנאביס הפרימיום Lord Jones® בישראל. ההשקה מהווה אבן דרך משמעותית באסטרטגיית המוצרים חוצת הגבולות של קרונוס, ומרחיבה את פורטפוליו המותגים הבינלאומי והמוערך של החברה לאחד משווקי הקנאביס המתקדמים, המקצועיים ומבעלי הסטנדרטים הגבוהים בעולם. השלב הראשון של ההשקה כולל חמישה זני תפרחות פרימיום, שגודלו בגידול...

February 2, 2026 1 EN
 PRESS RELEASE
Free
A2DMQY Cronos Group In...

Cronos Group Launches Premium Lord Jones® Brand in Israel, Advancing B...

Cronos Group Launches Premium Lord Jones® Brand in Israel, Advancing Borderless Product Strategy TORONTO, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON; TSX: CRON) (“Cronos” or the “Company”), a leading global cannabinoid company, today announced the launch of its Lord Jones® premium cannabis brand in Israel. The introduction marks a significant milestone in Cronos’ borderless product strategy, expanding the Company’s globally recognized brand portfolio into one of the most advanced and discerning medical cannabis markets in the world. The first phase of the launch br...

February 2, 2026 1 EN
 PRESS RELEASE
Free
A2DMQY Cronos Group In...

Cronos to enter the Netherlands with acquisition of Europe’s largest a...

Cronos to enter the Netherlands with acquisition of Europe’s largest adult-use cannabis company Cronos to acquire CanAdelaar for up-front cash consideration of US$67.0M1 plus cash earnout of 0.5x normalized EBITDA in 2026 and 2027 Up-front consideration represents approximately 1.4x CanAdelaar LTM revenue and 2.4x LTM EBITDA2 Will give Cronos #1 market share3 in the largest adult-use cannabis market in Europe Enables borderless product strategy, leveraging investments in genetics, R&D, and product development TORONTO, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON)...

December 9, 2025 1 EN
 PRESS RELEASE
Free
A2DMQY Cronos Group In...

Cronos Launches Premium Lord Jones Live Resin Fusions™ in Canada

Cronos Launches Premium Lord Jones Live Resin Fusions™ in Canada TORONTO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced is expanding its portfolio for its Lord Jones® brand with new innovations designed to enhance its lineup of premium cannabis products in the Canadian market. The new Lord Jones Live Resin Fusions™ pre-rolls combine top-tier craftsmanship with exceptional cannabis genetics, reflecting the brand’s continued dedication to quality and refinement. The Lord ...

November 25, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch